Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-012351
Filing Date
2025-02-03
Accepted
2025-02-03 16:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 45727
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 98907
  Complete submission text file 0000950170-25-012351.txt   183610
Mailing Address 1275 MARKET STREET SAN FRANCISCO CA 94103
Business Address 1275 MARKET STREET SAN FRANCISCO CA 94103 415 558 0200
Dolby Laboratories, Inc. (Subject) CIK: 0001308547 (see all company filings)

EIN.: 900199783 | State of Incorp.: DE | Fiscal Year End: 0927
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-80595 | Film No.: 25582964
SIC: 6794 Patent Owners & Lessors
(CF Office: 05 Real Estate & Construction)

Mailing Address C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103
Business Address
Dolby Dagmar (Filed by) CIK: 0001537372 (see all company filings)

Type: SCHEDULE 13D/A